Your browser doesn't support javascript.
loading
Combining 5-azacitidine with the E-selectin antagonist uproleselan is an effective strategy to augment responses in myelodysplasia and acute myeloid leukaemia.
Enjeti, Anoop K; Fogler, William E; Smith, Theodore A G; Lincz, Lisa F; Bond, Danielle R; Magnani, John L.
Afiliação
  • Enjeti AK; Calvary Mater Newcastle Hospital, Waratah, New South Wales, Australia.
  • Fogler WE; NSW Health Pathology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
  • Smith TAG; Precision Medicine Program, Hunter Medical Research Institute and University of Newcastle, New Lambton Heights, New South Wales, Australia.
  • Lincz LF; University of Newcastle, Callagan, NSW, Australia.
  • Bond DR; GlycoMimetics, Inc., Rockville, Maryland, USA.
  • Magnani JL; GlycoMimetics, Inc., Rockville, Maryland, USA.
Br J Haematol ; 204(6): 2264-2274, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38659295

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Selectina E Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Selectina E Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article